Inici › Insuficiència cardíaca › Arizona › Phoenix
Assaigs clínics de Insuficiència cardíaca a Phoenix, AZ
18 estudis de Insuficiència cardíaca busquen participants en centres de Phoenix i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
ELEVATE-HFpEF Clinical Study
Reclutant
- Banner - University Medical Center Phoenix, Phoenix
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
ReclutantFase 3
- Research Site, Phoenix
- Research Site, Phoenix
BiVACOR® Total Artificial Heart Early Feasibility Study
Reclutant
- Banner - University Medical Center Phoenix, Phoenix
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ReclutantFase 3
- HonorHealth, Phoenix
- Medical Advancement Centers of Arizona, Phoenix
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
ReclutantFase 3
- Phoenix, AZ Investigative Site CON-10115, Phoenix
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
ReclutantFase 3
- Phoenix, AZ Investigative Site 10115, Phoenix
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Reclutant
- Mayo Clinic Phoenix, Phoenix
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Reclutant
- Banner--University Medical Center Phoenix, Phoenix
- Mayo Clinic - Arizona, Phoenix
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
ReclutantFase 3
- Honor Health, Phoenix
- Arizona Research Center, Phoenix
Assessment of CCM in HF With Higher Ejection Fraction
Reclutant
- Arizona Heart Rhythm, Phoenix
- Cardiovascular Consultants, Ltd, Phoenix
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
ReclutantFase 3
- Phoenix, AZ Investigative Site FIN-10115, Phoenix
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Reclutant
- St. Joseph's Hospital and Medical Center, Phoenix
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Reclutant
- Banner-University Medical Center Phoenix, Phoenix
CCM OPEN HF Registry
ReclutantEstudi observacional
- University of Arizona and Banner University Medical Center Phoenix, Phoenix
- HonorHealth Research Institute, Phoenix
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Reclutant
- Banner Health - Phoenix, Phoenix
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
Reclutant
- Arizona Heart Foundation, Phoenix
His-Bundle Corrective Pacing in Heart Failure
Reclutant
- University of Arizona, Phoenix
Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
ReclutantVoluntaris sans benvinguts
- Multiple Locations, Phoenix
Assaigs de Insuficiència cardíaca en altres ciutats
- New York City, NY51 estudis
- Boston, MA44 estudis
- Dallas, TX42 estudis
- Houston, TX36 estudis
- Cleveland, OH33 estudis
- Chicago, IL31 estudis
- Philadelphia, PA31 estudis
- San Francisco, CA29 estudis
- St. Louis, MO26 estudis
- Durham, NC26 estudis
- Kansas City, MO25 estudis
- Atlanta, GA25 estudis
Altres estudis a Phoenix
- Càncer de mama25 estudis
- Càncer colorrectal25 estudis
- Obesitat22 estudis
- Càncer de pulmó de cèl·lules no petites20 estudis
- Càncer metastàtic20 estudis
- Càncer de pròstata17 estudis
- Càncer (tots els tipus)17 estudis
- Mieloma múltiple16 estudis
- Càncer de pàncrees16 estudis
- Malaltia cardiovascular16 estudis
- Malaltia d'Alzheimer15 estudis
- Sobrepès15 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.